RWA Wealth Partners LLC Takes Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

RWA Wealth Partners LLC acquired a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 5,071 shares of the company’s stock, valued at approximately $392,000.

Other hedge funds have also recently bought and sold shares of the company. AE Wealth Management LLC lifted its position in shares of GE HealthCare Technologies by 4.0% in the third quarter. AE Wealth Management LLC now owns 10,810 shares of the company’s stock worth $735,000 after purchasing an additional 420 shares in the last quarter. IFP Advisors Inc lifted its position in GE HealthCare Technologies by 53.8% in the 3rd quarter. IFP Advisors Inc now owns 2,320 shares of the company’s stock worth $158,000 after buying an additional 812 shares in the last quarter. Avior Wealth Management LLC boosted its stake in shares of GE HealthCare Technologies by 35.5% during the 3rd quarter. Avior Wealth Management LLC now owns 1,369 shares of the company’s stock valued at $93,000 after buying an additional 359 shares during the period. Private Trust Co. NA grew its holdings in shares of GE HealthCare Technologies by 53.9% during the 3rd quarter. Private Trust Co. NA now owns 1,808 shares of the company’s stock valued at $123,000 after acquiring an additional 633 shares in the last quarter. Finally, SS&H Financial Advisors Inc. purchased a new position in shares of GE HealthCare Technologies during the 3rd quarter valued at $334,000. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $85.95 on Friday. The company has a market capitalization of $39.22 billion, a PE ratio of 28.46, a price-to-earnings-growth ratio of 3.02 and a beta of 0.94. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.05 and a quick ratio of 0.83. GE HealthCare Technologies Inc. has a one year low of $62.35 and a one year high of $94.50. The company’s fifty day moving average price is $88.91 and its 200 day moving average price is $78.32.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 EPS for the quarter, topping the consensus estimate of $1.07 by $0.11. The company had revenue of $5.20 billion for the quarter, compared to the consensus estimate of $5.09 billion. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The company’s revenue for the quarter was up 5.3% on a year-over-year basis. During the same period in the previous year, the business posted $1.31 EPS. As a group, analysts expect that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be given a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. The ex-dividend date is Thursday, April 18th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.97%.

Analysts Set New Price Targets

A number of research firms recently issued reports on GEHC. Mizuho lifted their price objective on GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, April 11th. Argus raised their price target on GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a research note on Monday, April 1st. HSBC started coverage on GE HealthCare Technologies in a research note on Thursday, February 15th. They issued a “buy” rating and a $100.00 price target for the company. Citigroup raised their price objective on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a research report on Wednesday, April 3rd. Finally, Morgan Stanley boosted their target price on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an “equal weight” rating in a research report on Monday, February 12th. Four research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $95.09.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.